JOHN GOETZ Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN GOETZ.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN GOETZ. JOHN GOETZ is EVP, Chief Operating Officer in BIO RAD LABORATORIES INC ($BIO).
Latest Insider Trading Transactions of JOHN GOETZ
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 159.32 | 1,600 | 254,912 | 6,400 | |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 139.56 | 1,600 | 223,296 | 4,800 | |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 119.54 | 1,200 | 143,448 | 2,400 | |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 117.00 | 640 | 74,880 | 640 | |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 107.32 | 650 | 69,758 | 0 | |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 220.47 | 1,388 | 306,012 | 66,473 | 67.9 K to 66.5 K (-2.05 %) |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 159.32 | 1,600 | 254,912 | 67,861 | 66.3 K to 67.9 K (+2.41 %) |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 220.47 | 1,320 | 291,020 | 66,261 | 67.6 K to 66.3 K (-1.95 %) |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 139.56 | 1,600 | 223,296 | 67,581 | 66 K to 67.6 K (+2.42 %) |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 220.47 | 938 | 206,801 | 65,981 | 66.9 K to 66 K (-1.40 %) |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 119.54 | 1,200 | 143,448 | 66,919 | 65.7 K to 66.9 K (+1.83 %) |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 220.47 | 497 | 109,574 | 65,719 | 66.2 K to 65.7 K (-0.75 %) |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 117.00 | 640 | 74,880 | 66,216 | 65.6 K to 66.2 K (+0.98 %) |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 220.47 | 491 | 108,251 | 65,576 | 66.1 K to 65.6 K (-0.74 %) |
| Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 107.32 | 650 | 69,758 | 66,067 | 65.4 K to 66.1 K (+0.99 %) |
| Sep 13 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 300 | 0 | 0 | |
| Sep 13 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 218.04 | 157 | 34,232 | 65,417 | 65.6 K to 65.4 K (-0.24 %) |
| Sep 13 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 300 | 0 | 65,574 | 65.3 K to 65.6 K (+0.46 %) |
| Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,600 | 0 | 4,800 | |
| Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 300 | 0 | 300 | |
| Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,200 | 0 | 2,400 | |
| Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 218.86 | 992 | 217,109 | 65,274 | 66.3 K to 65.3 K (-1.50 %) |
| Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,900 | 0 | 66,266 | 64.4 K to 66.3 K (+2.95 %) |
| Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 218.42 | 627 | 136,949 | 64,366 | 65 K to 64.4 K (-0.96 %) |
| Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,200 | 0 | 64,993 | 63.8 K to 65 K (+1.88 %) |
| Sep 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,600 | 0 | 6,400 | |
| Sep 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 215.44 | 835 | 179,892 | 63,793 | 64.6 K to 63.8 K (-1.29 %) |
| Sep 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,600 | 0 | 64,628 | 63 K to 64.6 K (+2.54 %) |
| Sep 06 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | A | 215.98 | 8,000 | 1,727,840 | 8,000 | |
| Sep 06 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 139.56 | 1,600 | 223,296 | 6,400 | |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 119.54 | 2,400 | 286,896 | 3,600 | |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 117.00 | 1,920 | 224,640 | 1,280 | |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 107.32 | 2,600 | 279,032 | 650 | |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 215.00 | 1,332 | 286,380 | 63,028 | 64.4 K to 63 K (-2.07 %) |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 139.56 | 1,600 | 223,296 | 64,360 | 62.8 K to 64.4 K (+2.55 %) |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 215.00 | 1,891 | 406,565 | 62,760 | 64.7 K to 62.8 K (-2.92 %) |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 119.54 | 2,400 | 286,896 | 64,651 | 62.3 K to 64.7 K (+3.86 %) |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 215.00 | 1,502 | 322,930 | 62,251 | 63.8 K to 62.3 K (-2.36 %) |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 117.00 | 1,920 | 224,640 | 63,753 | 61.8 K to 63.8 K (+3.11 %) |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 215.00 | 1,978 | 425,270 | 61,833 | 63.8 K to 61.8 K (-3.10 %) |
| Aug 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 107.32 | 2,600 | 279,032 | 63,811 | 61.2 K to 63.8 K (+4.25 %) |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 88.00 | 3,500 | 308,000 | 0 | |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 98.04 | 3,500 | 343,140 | 0 | |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 84.57 | 3,500 | 295,995 | 0 | |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 74.27 | 3,500 | 259,945 | 0 | |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Sell | S | 220.17 | 3,500 | 770,590 | 61,174 | 64.7 K to 61.2 K (-5.41 %) |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 88.00 | 3,500 | 308,000 | 64,674 | 61.2 K to 64.7 K (+5.72 %) |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 223.00 | 2,563 | 571,549 | 61,174 | 63.7 K to 61.2 K (-4.02 %) |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 98.04 | 3,500 | 343,140 | 63,737 | 60.2 K to 63.7 K (+5.81 %) |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 223.00 | 2,462 | 549,026 | 60,237 | 62.7 K to 60.2 K (-3.93 %) |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 84.57 | 3,500 | 295,995 | 62,699 | 59.2 K to 62.7 K (+5.91 %) |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 223.00 | 2,271 | 506,433 | 59,199 | 61.5 K to 59.2 K (-3.69 %) |
| May 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 74.27 | 3,500 | 259,945 | 61,470 | 58 K to 61.5 K (+6.04 %) |
| Mar 02 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 75.32 | 3,500 | 263,620 | 0 | |
| Mar 02 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Sell | S | 196.34 | 3,500 | 687,189 | 57,922 | 61.4 K to 57.9 K (-5.70 %) |
| Mar 02 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 75.32 | 3,500 | 263,620 | 61,422 | 57.9 K to 61.4 K (+6.04 %) |
| Nov 08 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 240 | 0 | 0 | |
| Nov 08 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 164.74 | 126 | 20,757 | 57,918 | 58 K to 57.9 K (-0.22 %) |
| Nov 08 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 240 | 0 | 58,044 | 57.8 K to 58 K (+0.42 %) |
| Sep 13 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 300 | 0 | 300 | |
| Sep 13 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,600 | 0 | 6,400 | |
| Sep 13 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 300 | 0 | 600 | |
| Sep 13 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,200 | 0 | 3,600 | |
| Sep 13 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 159.32 | 157 | 25,013 | 57,744 | 57.9 K to 57.7 K (-0.27 %) |
| Sep 13 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 300 | 0 | 57,901 | 57.6 K to 57.9 K (+0.52 %) |
| Sep 13 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 157.71 | 915 | 144,305 | 57,601 | 58.5 K to 57.6 K (-1.56 %) |
| Sep 13 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,900 | 0 | 58,516 | 56.6 K to 58.5 K (+3.36 %) |
| Sep 13 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 157.71 | 451 | 71,127 | 56,616 | 57.1 K to 56.6 K (-0.79 %) |
| Sep 13 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,200 | 0 | 57,067 | 55.9 K to 57.1 K (+2.15 %) |
| Sep 09 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | A | 159.32 | 8,000 | 1,274,560 | 8,000 | |
| Sep 09 2016 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
| Nov 05 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 240 | 0 | 240 | |
| Nov 05 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 240 | 0 | 55,744 | 55.5 K to 55.7 K (+0.43 %) |
| Sep 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 300 | 0 | 600 | |
| Sep 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 300 | 0 | 900 | |
| Sep 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | A | 139.56 | 8,000 | 1,116,480 | 8,000 | |
| Sep 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
| Sep 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,200 | 0 | 4,800 | |
| Sep 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 300 | 0 | 55,448 | 55.1 K to 55.4 K (+0.54 %) |
| Sep 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 300 | 0 | 55,148 | 54.8 K to 55.1 K (+0.55 %) |
| Sep 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,200 | 0 | 54,848 | 53.6 K to 54.8 K (+2.24 %) |
| Sep 10 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 240 | 0 | 0 | |
| Sep 10 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 240 | 0 | 53,648 | 53.4 K to 53.6 K (+0.45 %) |
| Aug 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 62.47 | 7,000 | 437,290 | 0 | |
| Aug 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Sell | S | 147.57 | 2,559 | 377,632 | 53,408 | 56 K to 53.4 K (-4.57 %) |
| Aug 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Sell | S | 146.75 | 1,999 | 293,353 | 55,967 | 58 K to 56 K (-3.45 %) |
| Aug 14 2015 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 62.47 | 7,000 | 437,290 | 57,966 | 51 K to 58 K (+13.73 %) |
Page: 1